Salivary, lacrimal and nasal (SALANS) measure to assess side effects following radioactive iodine treatment: development, psychometric properties, and factor structure

Jacqueline Jonklaas,Alaina L. Carr,George Luta,Chenlu Yu,Roxanne E. Jensen,Emma Reasner,Justin Winslow,Charlene C. Kuo,Bruce J. Davidson,Giuseppe Esposito,Gary Bloom,Samantha A. Diamond-Rossi,Kristi D. Graves
DOI: https://doi.org/10.1007/s11136-024-03684-2
2024-05-22
Quality of Life Research
Abstract:This study aimed to develop and psychometrically evaluate a patient-reported outcome measure (PROM), SAlivary, LAcrimal, NaSal (SALANS), to document patients' symptoms after radioactive iodine (RAI) treatment for differentiated thyroid cancer (DTC).
public, environmental & occupational health,health care sciences & services,health policy & services
What problem does this paper attempt to address?